Several lines of evidence support a fundamental role for
voltage-gated sodium channels in mediating ischemic Na rise. We examined the effect of the novel anti-ischemic compound
KC 12291 on
veratridine-stimulated and
lysophosphatidylcholine (LPC)-induced sustained
sodium current (I(NAL)) mediated by
sodium channels in isolated myocytes obtained from guinea-pig atria, by using the whole-cell patch-clamp technique. We also analyzed the effect of
KC 12291 on
veratridine- and LPC-induced
contractures in isolated guinea-pig atria.
Veratridine as well as LPC increased I(NAL) measured at 20 ms of a 2 s pulse evoked from -100 to -30 mV (47.5 and 12 pA/pF in the presence of 40 microM
veratridine and 10 microM LPC, respectively, vs. 6.7 pA/pF under control conditions). A significant reduction by
KC 12291 in the quantity of charge carried by
veratridine-stimulated I(NAL) in the range of test potentials between -50 mV and +10 mV was observed and similar effects were obtained on LPC-induced I(NAL). Thus, the quantity of charge carried by LPC-induced I(NAL) over a 2 s pulse to -30 mV was reduced by 48% in the presence of 10 microM
KC 12291 vs. a reduction by 50% of
veratridine-stimulated I(NAL) at the same test potential.
Veratridine- and LPC-induced submaximal
contractures in isolated atria were significantly inhibited by
KC 12291 in a concentration-dependent manner, with an IC of 0.55 microM and 0.79 microM, respectively. The data indicate that
veratridine- and LPC-induced increases in diastolic tension are inhibited by
KC 12291 by a mechanism that involves blockade of
voltage-gated sodium channels mediating sustained
sodium current.